Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.

ABSTRACT:

Background

Achievement of low-risk status is a treatment goal in pulmonary arterial hypertension (PAH). Risk assessment often is performed using multiparameter tools, such as the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) risk calculator. Risk calculators that assess fewer variables without compromising validity may expedite risk assessment in the routine clinic setting. We describe the development and validation of REVEAL Lite 2, an abridged version of REVEAL 2.0.

Research question

Can a simplified version of the REVEAL 2.0 risk assessment calculator for patients with PAH be developed and validated?

Study design and methods

REVEAL Lite 2 includes six noninvasive variables-functional class (FC), vital signs (systolic BP [SBP] and heart ra

SUBMITTER: Benza RL 

PROVIDER: S-EPMC7462639 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature